. A recent study published in Alzheimer's & Dementia found that older adults who received the two-dose recombinant shingles vaccine (Shingrix®) had a significantly lower risk of developing dementia, including Alzheimer's disease and vascular dementia, compared with those who were not vaccinated.
Публикация
Обсуждение
0 прямых ответов
Ответов пока нет
Обсуждение ещё не началось.